Evidence map›Paper›PMID 25237856›Full record

ReviewChemistry & biology2014

Click chemistry in complex mixtures: bioorthogonal bioconjugation.

Craig S McKay, M G Finn

Abstract readReview
In one paragraph

Review in Chemistry & biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 272 papers.

0numbers the graph read from it
0cells of the map it votes in
272citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

272 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Bioorthogonal tuning of nanosurface opsonisationChemical communications (Cambridge, England) · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Antibody-Empowered Nanomedicine for Precise Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  16. Protein Modification via Bioorthogonal HS-BCN Ligation.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  17. Review
  18. Review
  19. Review
  20. Review

212 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Craig S McKaySchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332, USA.
M G FinnSchool of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332, USA. Electronic address: mgfinn@gatech.edu.

Funding

Genetic and Chemically Programmed Nanoparticles for Prodrug TherapyR01GM101421 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI FINN, M.G. · 2013 to 2016
$1.1M
NIGMS NIH HHS R01 GM101421
6 · The paper itself

Abstract

The selective chemical modification of biological molecules drives a good portion of modern drug development and fundamental biological research. While a few early examples of reactions that engage amine and thiol groups on proteins helped establish the value of such processes, the development of reactions that avoid most biological molecules so as to achieve selectivity in desired bond-forming events has revolutionized the field. We provide an update on recent developments in bioorthogonal chemistry that highlights key advances in reaction rates, biocompatibility, and applications. While not exhaustive, we hope this summary allows the reader to appreciate the rich continuing development of good chemistry that operates in the biological setting.

Indexed as

Click ChemistryAldehydesAminesAmino AcidsHydroxidesKetonesOrganometallic CompoundsProdrugsProteinsAldehydesAminesAmino AcidsHydroxidesKetonesOrganometallic CompoundsProdrugsProteins

Identifiers

PMID25237856
PMCPMC4331201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.